While developing our BlueCap Technology, we realized the expansive value our biopolymer formulation can have in the world of animal health. There is an ongoing concern for the increase in antibiotic resistant bacteria. MiraBlue Bio is creating a non-antibiotic anti-microbial technology that can decrease the prevalence of Salmonella in broiler chickens, which decreases Salmonella-based food poisoning in humans!

Our technology is a controlled-release, anti-Salmonella bacteriophage drug that will be orally administered to broiler chickens. The novel bacteriophage concoction will be released in the lower gastrointestinal tract of broiler chickens to eliminate Salmonella colonization in-vivo. Upon completion of safety and toxicity trials, our patent- pending technology will be invaluable in the animal feed industry.